Sec Form 13D Filing - CONTINENTAL GENERAL INSURANCE CO filing for ALPHA METALLURGICAL RES INC CO (AMR) - 2024-03-19

CUSIP No. 020764106

The following constitutes Amendment No. 1 to the Schedule 13D filed by the undersigned (“Amendment No. 1”). This Amendment No. 1 amends the Schedule 13D as specifically set forth herein.

This Amendment No. 1 is being filed to reflect a change in beneficial ownership as a result of a decrease in the number of outstanding Shares as reported in the Issuer’s Quarterly Report on Form 10-Q and Annual Report on Form 10-K for the quarterly period ending September 30, 2023 and fiscal year ended December 31, 2023, respectively, filed with the Securities and Exchange Commission (SEC) on November 2, 2023 and February 26, 2024, respectively.

Item 3 is hereby restated to read as follows:

782,788 of the Shares directly owned by Percy Rockdale were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business). The aggregate purchase price of the 782,788 Shares directly owned by Percy Rockdale is approximately $7,972,376 excluding brokerage commissions. Percy Rockdale received 4,309 Shares upon the exercise of certain Series A Warrants (the “Series A Warrants”) previously held, which had an exercise price of $44.972 per Series A Warrant.

1,589 of the Shares directly owned by MG Capital Management were received in connection with a reorganization of the Issuer on account of certain bonds issued by a predecessor of the Issuer. MG Capital Management received 102 Shares upon the exercise of certain Series A Warrants previously held, which had an exercise price of $44.972 per Series A Warrant.

The Shares directly owned by CGIC were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business). The aggregate purchase price of the 605,449 Shares directly owned by CGIC is approximately $26,975,709, excluding brokerage commissions.

Mr. Gorzynski acquired 1,810 Shares underlying certain RSUs, inclusive of 1,586 Shares underlying RSUs that will vest on May 2, 2024, in connection with his service as a director of the Issuer. The RSUs settle on a deferred basis upon Mr. Gorzynski's separation from service from the Issuer.

Items 5 (a) – (c) are hereby restated to read as follows:

(a) – (b) The aggregate percentage of shares of Common Stock for the MG Reporting Persons and Mr. Gorzynski reported herein is based upon 13,007,215 Shares, which is the total number of outstanding Shares as of March 8, 2024 as reported in the Issuer’s Preliminary Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on March 15, 2024.

As of the date hereof, Percy Rockdale beneficially owned 787,097 Shares, constituting approximately 6.1% of the Shares outstanding. As of the date hereof, MG Capital Management beneficially owned 1,691 Shares, constituting less than 1% of the Shares outstanding. By virtue of his relationships with Percy Rockdale and MG Capital Management, as discussed in further detail in Item 2, Mr. Gorzynski may be deemed to beneficially own the Shares beneficially owned by each of Percy Rockdale and MG Capital Management. Percy Rockdale and Mr. Gorzynski have shared voting and dispositive power over the Shares and warrants directly held by Percy Rockdale. MG Capital Management and Mr. Gorzynski have shared voting and dispositive power over the Shares and warrants directly held by MG Capital Management.

As of the date hereof, Mr. Gorzynski directly beneficially owned 1,810 Shares underlying certain RSUs, inclusive of 1,586 Shares underlying RSUs that will vest on May 2, 2024, and excludes 4,486 Shares held by Mr. Gorzynski’s spouse, constituting less than 1% of the Shares outstanding. Mr. Gorzynski disclaims beneficial ownership of the Shares held directly by his spouse.

As of the date hereof, CGIC may be deemed to beneficially own 605,449 Shares constituting approximately 4.7% of the Shares outstanding. By virtue of its relationship with CGIC discussed in further detail in Item 2, CIG may be deemed the beneficial owner of the Shares beneficially owned by CGIC. By virtue of its relationship with CIG discussed in further detail in Item 2, CGH may be deemed the beneficial owner of the Shares beneficially owned by CGIC. By virtue of his relationship with CGH discussed in further detail in Item 2, Mr. Gorzynski may be deemed the beneficial owner of the Shares beneficially owned by CGIC. CGH, CIG, CGIC and Mr. Gorzynski have shared voting and dispositive power over the Shares directly held by CGIC.

(c)       On February 29, 2024, Mr. Gorzynski received a grant of 27 RSUs in connection with his service as a director of the Issuer as discussed in further detail in Item 3. Except as set forth on the Schedule A hereto, the Reporting Persons have not entered into any transactions in the Shares during the past sixty days. All transactions included on Schedule A were effected in the open market unless otherwise noted therein.

As of the date hereof, the Reporting Persons beneficially own an aggregate of 1,396,047 Shares, constituting approximately 10.7% of the outstanding Shares. The filing of this Schedule 13D shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any securities of the Issuer that he or it does not directly own. Each of the Reporting Persons specifically disclaims beneficial ownership of the securities reported herein that he or it does not directly own.

SIGNATURES

After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: March 19, 2024

SCHEDULE A

Transactions in the Securities of the Issuer During the Past 60 Days

CONTINENTAL GENERAL INSURANCE company

¹ The reported price represents a weighted average sale price. The range of prices at which Shares were sold was $ 291.2050 to $ 291.8550 per share. The Reporting Persons undertake to provide to the Staff, the Issuer or a security holder full information regarding the number of Shares sold at each separate price.

² The reported price represents a weighted average sale price. The range of prices at which Shares were sold was $ 292.2300 to $ 292.7650 per share. The Reporting Persons undertake to provide to the Staff, the Issuer or a security holder full information regarding the number of Shares sold at each separate price.

³ The reported price represents a weighted average sale price. The range of prices at which Shares were sold was $293.5300 to $293.6950 per share. The Reporting Persons undertake to provide to the Staff, the Issuer or a security holder full information regarding the number of Shares sold at each separate price.

⁴ The reported price represents a weighted average sale price. The range of prices at which Shares were sold was $294.5900 to $295.4200 per share. The Reporting Persons undertake to provide to the Staff, the Issuer or a security holder full information regarding the number of Shares sold at each separate price.

⁵ The reported price represents a weighted average sale price. The range of prices at which Shares were sold was $299.0450 to $300.0200 per share. The Reporting Persons undertake to provide to the Staff, the Issuer or a security holder full information regarding the number of Shares sold at each separate price.

⁶ The reported price represents a weighted average sale price. The range of prices at which Shares were sold was $300.0900 to $300.2750 per share. The Reporting Persons undertake to provide to the Staff, the Issuer or a security holder full information regarding the number of Shares sold at each separate price.